p19ras brings a new twist to the regulation of p73 by Mdm2.

Kelly Lynn Harms, Xinbin Chen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

p53 is the most commonly mutated gene in human cancer. It is now known that the p53 family proteins p63 and p73 play important roles in tumor suppression as well as in development. Because p63 and p73 are rarely mutated in human cancer, understanding the signaling pathways that activate p63 and p73 will not only shed light on the developmental processes regulated by p63 and p73 but may also yield insight into ways to harness p63 and p73 activity for cancer therapy. Recent research has shown that an alternative splice form of c-H-ras, called p19ras, is a positive regulator of p73beta through a mechanism that involves the E3 ubiquitin ligase Mdm2. Implications for this previously unidentified means of regulation are discussed in light of tumor suppression and are extended to p53 and p63.

Original languageEnglish (US)
JournalScience's STKE : signal transduction knowledge environment
Volume2006
Issue number337
DOIs
StatePublished - May 30 2006
Externally publishedYes

Fingerprint

Tumors
Ubiquitin-Protein Ligases
Neoplasms
Genes
Proteins
Research
Therapeutics

Cite this

p19ras brings a new twist to the regulation of p73 by Mdm2. / Harms, Kelly Lynn; Chen, Xinbin.

In: Science's STKE : signal transduction knowledge environment, Vol. 2006, No. 337, 30.05.2006.

Research output: Contribution to journalArticle

@article{3d1aee3469774c5d94aafff84d9b1bc9,
title = "p19ras brings a new twist to the regulation of p73 by Mdm2.",
abstract = "p53 is the most commonly mutated gene in human cancer. It is now known that the p53 family proteins p63 and p73 play important roles in tumor suppression as well as in development. Because p63 and p73 are rarely mutated in human cancer, understanding the signaling pathways that activate p63 and p73 will not only shed light on the developmental processes regulated by p63 and p73 but may also yield insight into ways to harness p63 and p73 activity for cancer therapy. Recent research has shown that an alternative splice form of c-H-ras, called p19ras, is a positive regulator of p73beta through a mechanism that involves the E3 ubiquitin ligase Mdm2. Implications for this previously unidentified means of regulation are discussed in light of tumor suppression and are extended to p53 and p63.",
author = "Harms, {Kelly Lynn} and Xinbin Chen",
year = "2006",
month = "5",
day = "30",
doi = "10.1126/stke.3372006pe24",
language = "English (US)",
volume = "2006",
journal = "Science Signaling",
issn = "1937-9145",
publisher = "American Association for the Advancement of Science",
number = "337",

}

TY - JOUR

T1 - p19ras brings a new twist to the regulation of p73 by Mdm2.

AU - Harms, Kelly Lynn

AU - Chen, Xinbin

PY - 2006/5/30

Y1 - 2006/5/30

N2 - p53 is the most commonly mutated gene in human cancer. It is now known that the p53 family proteins p63 and p73 play important roles in tumor suppression as well as in development. Because p63 and p73 are rarely mutated in human cancer, understanding the signaling pathways that activate p63 and p73 will not only shed light on the developmental processes regulated by p63 and p73 but may also yield insight into ways to harness p63 and p73 activity for cancer therapy. Recent research has shown that an alternative splice form of c-H-ras, called p19ras, is a positive regulator of p73beta through a mechanism that involves the E3 ubiquitin ligase Mdm2. Implications for this previously unidentified means of regulation are discussed in light of tumor suppression and are extended to p53 and p63.

AB - p53 is the most commonly mutated gene in human cancer. It is now known that the p53 family proteins p63 and p73 play important roles in tumor suppression as well as in development. Because p63 and p73 are rarely mutated in human cancer, understanding the signaling pathways that activate p63 and p73 will not only shed light on the developmental processes regulated by p63 and p73 but may also yield insight into ways to harness p63 and p73 activity for cancer therapy. Recent research has shown that an alternative splice form of c-H-ras, called p19ras, is a positive regulator of p73beta through a mechanism that involves the E3 ubiquitin ligase Mdm2. Implications for this previously unidentified means of regulation are discussed in light of tumor suppression and are extended to p53 and p63.

UR - http://www.scopus.com/inward/record.url?scp=33745318538&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745318538&partnerID=8YFLogxK

U2 - 10.1126/stke.3372006pe24

DO - 10.1126/stke.3372006pe24

M3 - Article

C2 - 16738062

AN - SCOPUS:33745318538

VL - 2006

JO - Science Signaling

JF - Science Signaling

SN - 1937-9145

IS - 337

ER -